Skip to Main Content

Paper Details

Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
Am J Med
24
2021
-CoV-2, COVID-19, IgG, SARS, SARS-, SARS-CoV, SARS-CoV-2-Specific IgG Antibodies, SARS-CoV-2-specific IgG antibodies, SARS-CoV-2-specific antibodies, immunoglobulin G, non, people, severe, severe acute respiratory syndrome coronavirus, women
Author NameAffiliation
Shiwani MahajanCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale School of Medicine
Shu-Xia LiCenter for Outcomes Research and Evaluation, Yale New Haven Hospital
Zhenqiu LinCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale School of Medicine
Albert I KoYale School of Public Health
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale School of Medicine, Yale School of Public Health
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, Yale School of Medicine, Yale School of Public Health
  • 1 - 6

Datasets

Release 1.2